Witnessing the stock’s movement on the chart, on Wednesday, OptimizeRx Corp (NASDAQ: OPRX) had a quiet start as it plunged -1.05% to $12.26, before settling in for the price of $12.39 at the close. Taking a more long-term approach, OPRX posted a 52-week range of $3.99-$22.25.
The Healthcare sector firm’s twelve-monthly sales growth has been -36.18% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -36.18%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 125.92%. This publicly-traded company’s shares outstanding now amounts to $18.59 million, simultaneously with a float of $15.44 million. The organization now has a market capitalization sitting at $228.54 million. At the time of writing, stock’s 50-day Moving Average stood at $15.63, while the 200-day Moving Average is $14.14.
OptimizeRx Corp (OPRX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Health Information Services industry. OptimizeRx Corp’s current insider ownership accounts for 17.19%, in contrast to 76.31% institutional ownership. According to the most recent insider trade that took place on Dec 19 ’25, this organization’s Chief Finance & Strat Officer sold 1,388 shares at the rate of 13.51, making the entire transaction reach 18,752 in total value, affecting insider ownership by 126,830. Preceding that transaction, on Oct 03 ’25, Company’s Chief Executive Officer sold 1,620 for 18.75, making the whole transaction’s value amount to 30,375. This particular insider is now the holder of 188,916 in total.
OptimizeRx Corp (OPRX) Earnings and Revenue Records
OptimizeRx Corp’s EPS increase for this current 12-month fiscal period is 125.92% and is forecasted to reach 0.86 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 45.21% through the next 5 years, which can be compared against the -36.18% growth it accomplished over the previous five years trading on the market.
OptimizeRx Corp (NASDAQ: OPRX) Trading Performance Indicators
Let’s observe the current performance indicators for OptimizeRx Corp (OPRX). It’s Quick Ratio in the last reported quarter now stands at 3.05. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.09. Similarly, its price to free cash flow for trailing twelve months is now 19.03.
In the same vein, OPRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.00, a figure that is expected to reach 0.22 in the next quarter, and analysts are predicting that it will be 0.86 at the market close of one year from today.
Technical Analysis of OptimizeRx Corp (OPRX)
Going through the that latest performance of [OptimizeRx Corp, OPRX]. Its last 5-days volume of 0.21 million was inferior to the volume of 0.36 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 9.29% While, its Average True Range was 28.76.
Raw Stochastic average of OptimizeRx Corp (OPRX) in the period of the previous 100 days is set at 1.38%, which indicates a major fall in contrast to 6.57% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.60 that was lower than 1.01 volatility it exhibited in the past 100-days period.
